Loading
Loading…
Loading…
Tender ID
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹12.0 LAccepted-Finance 2ND FLOOR PANCHRATNA OPP SAVAIGANDHARVA HALL NEW COTTON MARKET HUBBALLI KARNATAKA 580029 | DHARWAD | KARNATAKA | 580029 | L1 | Accepted-Finance Accepted | |
| 2 | L2₹13.6 L+₹1.6 L (13.1%)Accepted-Finance | L2 | Accepted-Finance Accepted | |
| 3 | L3₹1.0 Cr+₹90.2 L (752.5%)Accepted-Finance 10 11 KAVERI LANE CLUB ROAD EAST TAMBARAM EAST TAMBARAM EASTTAMBARAM KANCHIPURAM TAMIL NADU 600059 | CHENGALPATTU | TAMIL NADU | 600059 | L3 | Accepted-Finance Accepted | |
| 4 | Rejected-Technical | - | Rejected-Technical EMD and Tender fee not submitted as per the terms and conditions of the tender |
| Sl No | Description | Qty | Unit | RELIABLE PHARMA L2 | Shiva Medical Agencies L1 | GOWRI ENTERPRISES L3 |
|---|---|---|---|---|---|---|
| 1.00 | Cap.Amoxycillin-CV 625mg(Clavulanic acid) | 8,000 | Nos | 6.44 ₹51,520 | 5.67 ₹45,360 Lowest | 5.72 ₹45,760 |
| 2.00 | Cap. Amoxycillin (250mg) | 5,000 | Nos | 1.38 ₹6,900 | 1.28 ₹6,400 Lowest | 1.5 ₹7,500 |
| 3.00 | Tab. Amocycillin (250) mg DT | 6,000 | Nos | 1.69 ₹10,140 | 1.44 ₹8,640 Lowest | 1.67 ₹10,020 |
| 4.00 | Tab.Azithromycin (250 mg) | 6,000 | Nos | 5.34 ₹32,040 | 5 ₹30,000 | 4.63 ₹27,780 Lowest |
| 5.00 | Tab.Azithromycin (500 mg) | 1,500 | Nos | 10.88 ₹16,320 | 10.02 ₹15,030 | 9.33 ₹13,995 Lowest |
| 6.00 | Cap.Cephalexine (250mg) | 5,000 | Nos | 3.74 ₹18,700 | 2.67 ₹13,350 Lowest | 3.19 ₹15,950 |
| 7.00 | Tab.Cephalexine (250 mg) DT | 3,000 | Nos | 3.74 ₹11,220 | 2.67 ₹8,010 Lowest | 2.93 ₹8,790 |
| 8.00 | Tab. Cefixime (200 mg) | 5,000 | Nos | 3.99 ₹19,950 | 3.91 ₹19,550 Lowest | 4.08 ₹20,400 |
| 9.00 | Tab. Cefixime + Clavulanate- (325 mg) | 4,000 | Nos | 10.68 ₹42,720 | 11.16 ₹44,640 | 9.23 ₹36,920 Lowest |
| 10.00 | Tab. Ciprofloxacin (500 mg) | 3,000 | Nos | 2.22 ₹6,660 | 1.95 ₹5,850 Lowest | 2.23 ₹6,690 |
Tender Value
₹29.2 L
EMD Value
₹90,000
Closing Date
28 Sept 2026, 12:00 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
The CEO, Cantonment Board Wellington
Cantonment Board Wellington, The Nilgiris-643231
Supply of Medicines to Cantonment General Hospital, Wellington
2026_DGDE_788149_1
WCB/028/2026
Open Tender
Miscellaneous Goods
Supply
365 days
Cantonment Board Wellington
As per Tender Document
2 documents required · 2 mandatory
₹2,000
The CEO, Cantonment Board Wellington
₹90,000
7 Oct 2026
8 Sept 2026
29 Sept 2026
8 Sept 2026
28 Sept 2026
8 Sept 2026
8 Sept 2026 - 8 Sept 2026
| Sl No | Description | Qty | Unit | Est. Rate | Est. Amount |
|---|---|---|---|---|---|
| 1 | Cap.Amoxycillin-CV 625mg(Clavulanic acid) | 8,000 | Nos | 7.5 | ₹60,000 |
| 2 | Cap. Amoxycillin (250mg) | 5,000 | Nos | 0.33 | ₹1,650 |
| 3 | Tab. Amocycillin (250) mg DT | 6,000 | Nos | 1.74 | ₹10,440 |
| 4 | Tab.Azithromycin (250 mg) | 6,000 | Nos | 5.53 | ₹33,180 |
| 5 | Tab.Azithromycin (500 mg) | 1,500 | Nos | 10.96 | ₹16,440 |
| 6 | Cap.Cephalexine (250mg) | 5,000 | Nos | 3.3 | ₹16,500 |
| 7 | Tab.Cephalexine (250 mg) DT | 3,000 | Nos | 3.3 | ₹9,900 |
| 8 | Tab. Cefixime (200 mg) | 5,000 | Nos | 4.75 | ₹23,750 |
| 9 | Tab. Cefixime + Clavulanate- (325 mg) | 4,000 | Nos | 10.65 | ₹42,600 |
| 10 | Tab. Ciprofloxacin (500 mg) | 3,000 | Nos | 2.12 | ₹6,360 |
stage.html
html • 0.04 MB
tech_bid_open.pdf
tech_eval.pdf
fin_bid_open.pdf
boq_comp_chart.xlsx
xlsx
fin_eval.pdf
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Tendernotice_1.pdf
PDF • 0.30 MB
BOQ_883389.xls
BOQ • 0.42 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .